CClinicalTrials.gg
CompletedNCT02049684Updated Aug 19, 2019

SPARC: Shoulder PAtch for Rotator Cuff Tears

An observational study in Massive Rotator Cuff Tears, sponsored by The Leeds Teaching Hospitals NHS Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 95 Years. Per ClinicalTrials.gov, last updated 2019-08-19.

Sponsored by The Leeds Teaching Hospitals NHS Trust · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
60
Ages
18 Years to 95 Years
Sex
All
01

Study summary

Rotator cuff tears (injury to the muscle or tendons which stabilise the shoulder) are one of the most common conditions affecting the shoulder. Small and medium sized rotator cuff tears can be managed with arthroscopic or keyhole surgery. Very large or massive tears are difficult to operate on and often have poor rates of healing. As a result surgeons have investigated the use of products to improve the outcome of surgery on massive tears.

The product that the investigators are currently using to try to improve the outcome of surgery for massive rotator cuff tears is called a patch. The patch provides a scaffold to support the muscles of the rotator cuff. Studies of rotator cuff surgery using similar patches have found that recovery is improved and there is a lower rate of postsurgical problems. The aim of this study is to look at whether using the patch improves pain and the clinical function of the shoulder after surgery. In addition, the investigators would like to understand how the patch works. To do this the investigators will scan (take images of) the shoulder using magnetic resonance imaging to look at the muscle damage in the shoulder before and after surgery.

02

Conditions studied

  • Massive Rotator Cuff Tears

Browse trials for

03

In context

Rotator Cuff Injuries

734 studies on the registry are indexed under Rotator Cuff Injuries; 161 are open to participants now.

This study's enrollment of 60 is below the median of 67 across 162 observational studies indexed under Rotator Cuff Injuries.

Browse Rotator Cuff Injuries studies →

Lead sponsor

The Leeds Teaching Hospitals NHS Trust is the lead sponsor of 95 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 95 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Massive rotator cuff tear patients

Inclusion criteria

  • Ultrasound confirming massive rotator full thickness tear, unacceptable pain and disability following conservative treatment, or previous surgery that has failed, deltoid muscle that is functional, and compliance with post operative rehabilitation.

Exclusion criteria

Exclusion Criteria:

  • History of infection
  • Neurological condition that affects the shoulder girdle
  • Presence of rotator cuff arthropathy with stiffness
  • Subjects with inability to give informed consent
  • Pregnancy or lactation
  • Malignancy
  • Age less than 18 years
  • Subjects currently participating in other research studies
  • Subjects with the following contraindications to MRI scanning will not have an MR scan but may be asked to have alternative imaging, for example ultrasound:

    • Pacemakers
    • Surgical clips within the head
    • Certain inner ear implants
    • Neuroelectrical stimulators
    • Metal fragments within the eye or head
    • Pregnant or breastfeeding women
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
60 participants (actual)
Patient registry
No

Groups and cohorts

  • Surgery

    Procedure: Patch

  • Physiotherapy

Interventions

  • ProcedurePatch
06

What researchers measure

Primary outcomes

  1. Change in supraspinatus, infraspinatous and subscapularis water:fat ratio

    Change in supraspinatus, infraspinatous and subscapularis water:fat ratio, assessed by MRI, 6 months postsurgery/ physiotherapy compared to baseline (presurgery/physiotherapy)

    Time frame: Baseline and 6 months post surgery

Secondary outcomes

  1. Change in function, pain and patient satisfaction (Oxford Shoulder Score, EQ5D, Constant Score)

    Change in function, pain and patient satisfaction (Oxford Shoulder Score, EQ5D, Constant Score)

    Time frame: Baseline and 6 months post surgery

  2. Change in muscle volume (MRI assessment) for the supraspinatus, infraspinatous and subscapularis

    Change in muscle volume (MRI assessment) for the supraspinatus, infraspinatous and subscapularis

    Time frame: Baseline and 6 months post-surgery

  3. Change in Goutallier score of muscle atrophy and fatty infiltration (MRI assessment) for the supraspinatus, infraspinatous and subscapularis

    Change in Goutallier score of muscle atrophy and fatty infiltration (MRI assessment) for the supraspinatus, infraspinatous and subscapularis

    Time frame: Baseline and 6 months post-surgery

07

Study locations

1 site
  • Leeds Teaching Hospital NHS Trust
    Leeds, LS7 4SA, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 19, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02049684
Lead sponsor
The Leeds Teaching Hospitals NHS Trust
Responsible party
Sponsor
First posted
Jan 30, 2014
Start date
Jan 1, 2013
Primary completion
Mar 31, 2018
Completion
Mar 31, 2018
Last update
Aug 19, 2019
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion